The Surfactant System of the Lung

Gene structure of the pulmonary surfactant proteins SP-A, SP-B and SP-C, J.A.Whitsett; pulmonary surfactant-associated proteins - their role in surface tension reduction, F.Possmayer et al; mesenchymal-epithelial interactions during late fetal lung development, I.Caniggia and M.Post; effects of cortico steroids on fetal lung maturation, M.M.Anceschi et al; biological approaches to the prevention of RDS, B.T.Smith; disorders of surfactant in infants and vitamin D deficiency, E.M.Lukyanova; the relevance of surfactant intactivation by anti-surfactant antibodies to the evaluation of therapies for neo-natal RDS, D.S.Strayer; risk factors for respiratory distress syndrome in preterm newborns, M.Luerti et al; development, indication and present status of "late" amniocentesis in pregnancy, W.Schmidt et al; comparison of one-dimensional L/S ratio, enzymatic lecithin determination and surfactant/albumin-ratio using flourescence polarization by the determination of fetal lung maturity, V.Ragosch et al; antenatal glucocorticoids treatment in the prevention of neonatal RDS, V.Ragosh et al; induction of fetal pulmonary maturity with ambroxol - side effects and therapeutic effectiveness, A.Revelli et al; the combination of betamethasone and ambroxol for the prophylaxis of neonatal respiratory distress syndrome, F.Zullo et al; prevention of HMD and survival in low-birth-weight infants, A.Scarcella et al; RDS and the use of corticosteroids, J.G.Koppe and H.Smolders-de Haas; surfactant function - is it influenced by artificial ventilation?, J.Bos and B.Lachmann; experiences with curosurf in Europe, B.Robertson; further experiences with curosurf in Europe, H.L.Halliday and T.R.J.Tubman; curosurf for therapy in neonatal RDS - an Italian randomized clinical trial, G.Bevilacqua; early experiences with curosurf therapy for severe neonatal respiratory distress syndrome, G.Devai and B.Buky; preliminary results in the use of a natural surfactant in four infants with severe respiratory distress syndrome, B.Foresti and G.Marraro; incidence and outcome of persistant ductus arteriosus in premature babies treated with surfactant for severe respiratory distress syndrome, T.Troester et al; the effect of natural porcine surfactant on phagocytosis-associated functions of human neutrophils, C.P.Speer et al; surfactant replacement in severe respiratory distress syndrome - effects of perinatal acidosis on the theraupetic response, E.Herting et al; surfactant therapy and IG E levels in the neonatal period, M.Amato et al; pulmonary function in mechanicallyt ventilated surfactant-treated preterm infants, F.Mosca et al. Part Contents.